Gene · 9869
Papers2,616
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,616
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TERRA beyond cancer: the biology of telomeric repeat-containing RNAs in somatic and germ cells. | Front Aging | 2023 | 37636218 | PubTator, text mining | PubMed |
| Histone Modification of Colorectal Cancer by Natural Products. | Pharmaceuticals (Basel) | 2023 | 37631010 | PubTator, text mining | PubMed |
| A Novel Genetic Variant in MBD5 Associated with Severe Epilepsy and Intellectual Disability: Potential Implications on Neural Primary Cilia. | Int J Mol Sci | 2023 | 37628781 | PubTator, text mining | PubMed |
| Children with Chronic Immune Thrombocytopenia Exhibit High Expression of Human Endogenous Retroviruses TRIM28 and SETDB1. | Genes (Basel) | 2023 | 37628621 | PubTator, text mining | PubMed |
| Methylation across the central dogma in health and diseases: new therapeutic strategies. | Signal Transduct Target Ther | 2023 | 37620312 | PubTator, text mining | PubMed |
| 27-Hydroxycholesterol represses G9a expression via oestrogen receptor alpha in breast cancer. | J Cell Mol Med | 2023 | 37614064 | PubTator, text mining | PubMed |
| Histidine N1-position-specific methyltransferase CARNMT1 targets C3H zinc finger proteins and modulates RNA metabolism. | Genes Dev | 2023 | 37612136 | PubTator, text mining | PubMed |
| Machine learning-based on cytotoxic T lymphocyte evasion gene develops a novel signature to predict prognosis and immunotherapy responses for kidney renal clear cell carcinoma patients. | Front Immunol | 2023 | 37600786 | PubTator, text mining | PubMed |
| XAF1 promotes anti-RNA virus immune responses by regulating chromatin accessibility. | Sci Adv | 2023 | 37595039 | PubTator, text mining | PubMed |
| Pharmacological perturbation of the phase-separating protein SMNDC1. | Nat Commun | 2023 | 37587144 | PubTator, text mining | PubMed |
| SETD1A drives stemness by reprogramming the epigenetic landscape in hepatocellular carcinoma stem cells. | JCI Insight | 2023 | 37581938 | PubTator, text mining | PubMed |
| Gene-Smoking Interaction Analysis for the Identification of Novel Asthma-Associated Genetic Factors. | Int J Mol Sci | 2023 | 37569643 | PubTator, text mining | PubMed |
| In Vivo Identification of H3K9me2/H3K79me3 as an Epigenetic Barrier to Carcinogenesis. | Int J Mol Sci | 2023 | 37569534 | PubTator, text mining | PubMed |
| Lysine N-methyltransferase SETD7 promotes bladder cancer progression and immune escape via STAT3/PD-L1 cascade. | Int J Biol Sci | 2023 | 37564199 | PubTator, text mining | PubMed |
| The cytoplasmic fraction of the histone lysine methyltransferase Setdb1 is essential for embryonic stem cells. | iScience | 2023 | 37559904 | PubTator, text mining | PubMed |
| Unreprogrammed H3K9me3 prevents minor zygotic genome activation and lineage commitment in SCNT embryos. | Nat Commun | 2023 | 37558707 | PubTator, text mining | PubMed |
| Transcription factor FOXM1 promotes hepatocellular carcinoma malignant progression through activation of the WNT pathway by binding to SETDB1. | Tissue Cell | 2023 | 37556918 | PubTator, text mining | PubMed |
| SETDB1 Triple Tudor Domain Ligand, (R,R)-59, Promotes Methylation of Akt1 in Cells. | ACS Chem Biol | 2023 | 37556795 | PubTator, text mining | PubMed |
| H3K4 trimethylation regulates cancer immunity: a promising therapeutic target in combination with immunotherapy. | J Immunother Cancer | 2023 | 37553181 | PubTator, text mining | PubMed |
| Epigenetic reprogramming during the maternal-to-zygotic transition. | MedComm (2020) | 2023 | 37547174 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9869/papers?page=15